Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
Seeking Alpha
Friday, November 27, 2009 - 10:26am
tags:
Mead Johnson, Bristol-Myers Squibb
FDA grants full approval to J&J's HIV drug
Yahoo/AP
Wednesday, November 25, 2009 - 4:40pm
tags:
HIV, JNJ, FDA, Tibotec
A Big Upgrade for Amylin Pharmaceuticals
Motley Fool
Wednesday, November 25, 2009 - 4:38pm
tags:
Amylin, upgrades
Prospecting for Stocks: Novartis
Motley Fool
Wednesday, November 25, 2009 - 4:33pm
tags:
Novartis
Still Enjoying Those Acquisitions, Pfizer?
Motley Fool
Wednesday, November 25, 2009 - 4:29pm
tags:
Pfizer, Pharmacia, Warner-Lambert, Wyeth, M&A
A Schizophrenic Move by Merck?
Motley Fool
Wednesday, November 25, 2009 - 4:20pm
tags:
Merck, Schering Plough
Merck cholesterol scrips drop as Niaspan rises
Fierce Pharma
Wednesday, November 25, 2009 - 4:17pm
tags:
cholesterol, Niaspan, Merck, Zetia
Roche CEO sees group outpacing market in 2009-paper
Reuters
Wednesday, November 25, 2009 - 8:56am
tags:
Roche, diagnostics, Pharma CEOs, Severin Schwan
Novartis terminates pact with Idera
Marketwatch
Wednesday, November 25, 2009 - 8:56am
tags:
Novartis, partnerships, Idera Pharmaceuticals
Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN
Yahoo
Wednesday, November 25, 2009 - 8:05am
tags:
FDA, Zalbin, Human Genome Sciences
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate
Seeking Alpha
Wednesday, November 25, 2009 - 7:45am
tags:
Genzyme, Renagel, Renvela
Merger distracts Pfizer from biotech incubator
Fierce Biotech
Wednesday, November 25, 2009 - 7:41am
tags:
Pfizer, biotech, start-ups
Novartis Looks at Combination Pills to Fix Hypertension Franchise
BNET Pharma
Wednesday, November 25, 2009 - 7:39am
tags:
hypertension, Novartis, Diovan, Exforge
Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife
Seeking Alpha
Wednesday, November 25, 2009 - 7:37am
tags:
Pressure BioSciences, Protox
Pfizer's Kindler advises executive soul-searching
Fierce Pharma
Wednesday, November 25, 2009 - 6:04am
tags:
Pfizer, Jeff Kindler, Pharma CEOs
Vaccine Makers Struggle to Speed Output
WSJ Online
Wednesday, November 25, 2009 - 6:02am
tags:
vaccines, Flu, Novartis
Health-Care Bill May Be Stalled by Year-End Legislative Crunch
Bloomberg
Wednesday, November 25, 2009 - 5:58am
tags:
healthcare bill, healthcare reform
The Vytorin Limbo: How Low Can You Go?
Pharmalot
Wednesday, November 25, 2009 - 5:56am
tags:
Vytorin, Abbott Laboratories, Merck, Niaspan
Incyte to license 2 hematology drugs to Novartis
Marketwatch
Wednesday, November 25, 2009 - 5:55am
tags:
Novartis, Incyte, hematology, oncology
Can Drug & Device Makers Innovate Themselves to Extinction?
WSJ Online
Tuesday, November 24, 2009 - 9:40pm
tags:
innovation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.